Intravaginal probiotics before embryo transfer do not improve pregnancy rates in recurrent implantation failure cases: An RCT

Mina Naghi Jafarabadi, Farnaz Hadavi, Maedeh Ahmadi, Masoumeh Masoumi, Sara Zabihzadeh
{"title":"Intravaginal probiotics before embryo transfer do not improve pregnancy rates in recurrent implantation failure cases: An RCT","authors":"Mina Naghi Jafarabadi, Farnaz Hadavi, Maedeh Ahmadi, Masoumeh Masoumi, Sara Zabihzadeh","doi":"10.18502/ijrm.v22i5.16435","DOIUrl":null,"url":null,"abstract":"Background: Considering the considerable influence of the vaginal microbiome on endometrial receptivity and embryo implantation, we hypothesized that cases of recurrent implantation failure (RIF) might benefit from the intravaginal probiotic administration. \nObjective: Evaluation of the effects of intravaginal probiotic administration before frozen embryo transfer (FET) on the rates of pregnancy and the status of vaginal lactobacillary flora in cases of RIF. \nMaterials and Methods: This was a randomized, parallel-group, clinical trial conducted at an infertility clinic in Tehran, Iran between January 2021 and September 2022. A total of 166 reproductive-aged women with a history of unexplained RIF were randomly assigned to either the probiotic group or the control group (n = 83/each group). The probiotic group received intravaginal probiotics (LactoVag ®) daily for 2 wk from the second day of the menstrual cycle along with the routine treatment of FET. The control group received only the routine treatment of FET. The primary outcome was the chemical pregnancy rate, and the secondary outcomes were the clinical pregnancy rate and the status of vaginal lactobacillary flora. \nResults: A total of 163 participants were included in the final analysis. The probiotic group had a slightly higher chemical pregnancy rate than the control group (39.02% vs. 33.33%), but the difference was not statistically significant (risk ratio: 1.71, 95% CI: 0.77–1.76; p = 0.449). The clinical pregnancy rate was also non-significantly higher in the probiotic group than the control group (37.80% vs. 33.33%; RR: 1.14, 95% CI: 0.76–1.74; p = 0.623). \nConclusion: Intravaginal probiotic administration did not significantly improve the pregnancy rates in RIF cases undergoing FET. Further studies are needed to explore the optimal dose, duration, and timing of probiotic administration, as well as the mechanisms of action and the potential adverse effects of probiotics on the vaginal microbiome and the implantation process. \nKey words: Assisted reproductive technique, Probiotics, Microbiota, Pregnancy rate","PeriodicalId":318611,"journal":{"name":"International Journal of Reproductive BioMedicine (IJRM)","volume":"41 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Reproductive BioMedicine (IJRM)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijrm.v22i5.16435","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Considering the considerable influence of the vaginal microbiome on endometrial receptivity and embryo implantation, we hypothesized that cases of recurrent implantation failure (RIF) might benefit from the intravaginal probiotic administration. Objective: Evaluation of the effects of intravaginal probiotic administration before frozen embryo transfer (FET) on the rates of pregnancy and the status of vaginal lactobacillary flora in cases of RIF. Materials and Methods: This was a randomized, parallel-group, clinical trial conducted at an infertility clinic in Tehran, Iran between January 2021 and September 2022. A total of 166 reproductive-aged women with a history of unexplained RIF were randomly assigned to either the probiotic group or the control group (n = 83/each group). The probiotic group received intravaginal probiotics (LactoVag ®) daily for 2 wk from the second day of the menstrual cycle along with the routine treatment of FET. The control group received only the routine treatment of FET. The primary outcome was the chemical pregnancy rate, and the secondary outcomes were the clinical pregnancy rate and the status of vaginal lactobacillary flora. Results: A total of 163 participants were included in the final analysis. The probiotic group had a slightly higher chemical pregnancy rate than the control group (39.02% vs. 33.33%), but the difference was not statistically significant (risk ratio: 1.71, 95% CI: 0.77–1.76; p = 0.449). The clinical pregnancy rate was also non-significantly higher in the probiotic group than the control group (37.80% vs. 33.33%; RR: 1.14, 95% CI: 0.76–1.74; p = 0.623). Conclusion: Intravaginal probiotic administration did not significantly improve the pregnancy rates in RIF cases undergoing FET. Further studies are needed to explore the optimal dose, duration, and timing of probiotic administration, as well as the mechanisms of action and the potential adverse effects of probiotics on the vaginal microbiome and the implantation process. Key words: Assisted reproductive technique, Probiotics, Microbiota, Pregnancy rate
胚胎移植前阴道内使用益生菌并不能提高复发性植入失败病例的妊娠率:一项 RCT 研究
背景:考虑到阴道微生物群对子宫内膜接受性和胚胎着床有相当大的影响,我们假设复发性着床失败(RIF)病例可能会从阴道内服用益生菌中获益。研究目的评估在冷冻胚胎移植(FET)前阴道内使用益生菌对RIF病例的妊娠率和阴道乳酸菌群状况的影响。材料与方法:这是一项随机、平行组临床试验,于 2021 年 1 月至 2022 年 9 月期间在伊朗德黑兰的一家不孕不育诊所进行。共有 166 名育龄妇女被随机分配到益生菌组或对照组(n = 83/每组)。益生菌组从月经周期的第二天开始,每天在阴道内服用益生菌(LactoVag ®),持续 2 周,同时接受 FET 的常规治疗。对照组只接受 FET 常规治疗。主要结果是化学妊娠率,次要结果是临床妊娠率和阴道乳酸菌群状况。研究结果共有 163 名参与者参与了最终分析。益生菌组的化学妊娠率略高于对照组(39.02% 对 33.33%),但差异无统计学意义(风险比:1.71,95% CI:0.77-1.76;P = 0.449)。益生菌组的临床妊娠率也显著高于对照组(37.80% vs. 33.33%;RR:1.14,95% CI:0.76-1.74;P = 0.623)。结论阴道内使用益生菌并不能显著提高接受 FET 的 RIF 病例的妊娠率。需要进一步研究探讨益生菌的最佳剂量、持续时间和给药时机,以及益生菌对阴道微生物组和植入过程的作用机制和潜在不良影响。关键字辅助生殖技术 益生菌 微生物群 妊娠率
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信